| Variable | Study population (n = 616) | No endpoint (n = 602) | With endpoint (n = 14) | p-value | |
| Age | 67.6 (±8.1) | 67.6 (±8.1) | 66.8 (±7.6) | 0.71 | |
| Male Sex | 300 (48.7) | 292 (48.5) | 8 (57.1) | 0.523 | |
| BMI | 27.9 (±4.8) | 27.9 (±4.8) | 28.3 (±5.1) | 0.756 | |
| Arterial Hypertension | 521 (84.6) | 512 (85) | 9 (64.3) | 0.033 | |
| Dyslipidemia | 189 (30.7) | 186 (30.9) | 3 (21.4) | 0.448 | |
| Diabetes Mellitus | 158 (25.6) | 155 (25.7) | 3 (21.4) | 0.714 | |
| Positive Family History for CHD | 121 (19.6) | 120 (19.9) | 1 (7.1) | 0.234 | |
| Active Smoking | 147 (23.9) | 143 (23.8) | 4 (28.6) | 0.676 | |
| CHD | 86 (14) | 82 (13.6) | 4 (28.6) | 0.111 | |
| CHD in Angiography | 40 (6.5) | 38 (6.3) | 2 (14.3) | 0.231 | |
| Prior MI | 51 (8.3) | 47 (7.8) | 4 (28.6) | 0.005 | |
| Prior PCI | 46 (7.5) | 45 (7.5) | 1 (7.1) | 0.963 | |
| Prior ACB-OP | 24 (3.9) | 23 (3.8) | 1 (7.1) | 0.525 | |
| Prior Cerebral Infarction | 40 (6.5) | 37 (6.1) | 3 (21.4) | 0.022 | |
| PAOD | 123 (20) | 119 (19.8) | 4 (28.6) | 0.417 | |
| Renal Insufficiency | 53 (8.6) | 52 (8.6) | 1 (7.1) | 0.844 | |
| Liver Disease | 20 (3.2) | 19 (3.2) | 1 (7.1) | 0.405 | |
| Chronic Pulmonary Disease | 91 (14.8) | 89 (14.8) | 2 (14.3) | 0.959 | |
| Malignant Disease | 149 (24.2) | 141 (23.4) | 8 (57.1) | 0.004 | |